Amarin Corporation PLC at Jefferies Healthcare Conference Transcript

Jun 07, 2023 / 12:00PM GMT
Michael Yee - Jefferies LLC - Analyst

All Right. Good morning, everyone. Well, thank you for joining us on this morning session here to kick off the 2023 Jefferies Global Healthcare Conference. I'm Michael Yee, Managing Director and one of the senior biotech analysts. Here with us up to kick off a session is Amarin, and up here with us is Aaron Berg, the Interim President and CEO, as well as Tom Reilly, the CFO, to join us for some fireside chats, Q&A, after some prepared remarks.

So with that, I'll turn it over to you and we'll have a discussion about Amarin.

Aaron Berg - Amarin Corporation PLC - Interim President & CEO

Thanks, Michael. Appreciate it, and thanks to everyone for starting your day with us. So I'll give you a brief update. First of all, we'll be making forward-looking statements and there are inherent risks involved. I won't take the time to read through the disclaimer there that you're all familiar with.

So just in terms of our 2023 highlights, it's been -- it's hard to believe half the year is over with already. Quite

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot